SCHEMBL16789068

SCHEMBL16789068

CN1CC[C@@H](OC(=O)C(NC(=O)OC(C)(C)C)c2ccccc2F)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ CHRM3 P20309 4/20 0.42
▸ CHRM4 P08173 2/20 0.42
▸ CHRM5 P08912 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40
▸ CHRNA7 P36544 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ HTR3A P46098 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ SCN9A Q15858 4/20 0.40
▸ SSTR1 P30872 1/20 0.39
▸ SSTR4 P31391 1/20 0.39
▸ GPR119 Q8TDV5 1/20 0.38
▸ MC4R P32245 1/20 0.38
▸ CHRM2 P08172 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16789059 0.94 CHRM3 (0.42) CHRM3CHRM4CHRM5CHRM1CHRNB2
SCHEMBL8512111 0.85 CYP2D6 (0.54) CYP2D6HTTCHRM3CHRM4CHRM5
SCHEMBL16789073 0.85 CYP2D6 (0.54) CYP2D6HTTCHRM3CHRM4CHRM5
SCHEMBL8512117 0.85 CYP2D6 (0.54) CYP2D6HTTCHRM3CHRM4CHRM5
SCHEMBL8516088 0.85 CYP2D6 (0.54) CYP2D6HTTCHRM3CHRM4CHRM5
SCHEMBL18268318 0.84 CHRM3 (0.46) CHRM3SCN9ASSTR1SSTR4MC4R
SCHEMBL16789060 0.83 BCHE (0.49) CHRM4
SCHEMBL8512242 0.81 CHRNA7 (0.51) CHRM3CHRM4CHRM5CHRM1CHRNB2
SCHEMBL8512249 0.81 CHRNA7 (0.51) CHRM3CHRM4CHRM5CHRM1CHRNB2
SCHEMBL16789066 0.80 CYP2D6 (0.64) CYP2D6HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3077385-B1 HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES CHIESI FARM SPA (IT) 2017-10-04 — — EP disclosed
US-9133185-B2 Heteroaryl derivatives CHIESI FARMACEUTICI S.P.A (IT) 2015-09-15 — — US disclosed
US-9133185-B2 Heteroaryl derivatives CHIESI FARMACEUTICI S.P.A (IT) 2015-09-15 — — US disclosed
US-20150158858-A1 HETEROARYL DERIVATIVES CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-11 — — US disclosed
US-20150158858-A1 HETEROARYL DERIVATIVES CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-11 — — US disclosed
WO-2015082616-A1 HETEROARYL DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150158858-A1 HETEROARYL DERIVATIVES PDE4A, PDE4B, PDE3A CYP2D6 483/4885HTT 4850/4885CHRM3 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback